...
首页> 外文期刊>Carcinogenesis >Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
【24h】

Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.

机译:乙型肝炎病毒基因型混合物,亚型C2和B2在肝细胞癌中的作用:与同一地区的慢性乙型肝炎和无症状携带者相比。

获取原文
获取原文并翻译 | 示例
           

摘要

The role of genotype mixture and subgenotypes remains controversial in determining the clinical outcome of chronic hepatitis B virus (HBV) infection. We aimed to determine their role on the development and the recurrence of hepatocellular carcinoma (HCC). HBV genotypes, serum viral load and hepatitis B e antigen (HBeAg) seroconversion were determined in 462 HCC patients, 234 chronic hepatitis patients and 425 asymptomatic carriers born in Eastern China. In the 462 HCC patients, 62 (13.4%), 337 (72.9%) and 49 (10.6%) had HBV subgenotype B2, C2 and genotype mixture, respectively. Genotype mixture in HCC patients and hepatitis patients was associated with higher viral load than HBV C2 (P = 0.012, P = 0.000) and more frequent than asymptomatic carriers (P = 0.005, P = 0.000). HBV C2 was more prevalent in HCC patients compared with controls. Proportion of HBV B2 in HCC patients decreased consecutively from <30 to 50-59 years group (P = 0.024). Age-related changes of HBeAg seroconversion were not consistent with serum viral load in HCC patients with HBV B2 and genotype mixture, quite in contrast to hepatitis patients. By multivariate regression analysis, age >or=40 years and serum viral load (>or=10 000 copies/ml) were independently associated with hepatocarcinogenesis, whereas age
机译:在确定慢性乙型肝炎病毒(HBV)感染的临床结果时,基因型混合物和亚基因型的作用仍存在争议。我们旨在确定其在肝细胞癌(HCC)的发展和复发中的作用。确定了华东地区出生的462例HCC患者,234例慢性肝炎患者和425例无症状携带者的HBV基因型,血清病毒载量和乙型肝炎e抗原血清转换。在462例HCC患者中,分别有HBV亚型B2,C2和基因型混合物,分别为62(13.4%),337(72.9%)和49(10.6%)。 HCC患者和肝炎患者中的基因型混合物与病毒载量相比高于HBV C2(P = 0.012,P = 0.000),并且比无症状携带者更常见(P = 0.005,P = 0.000)。与对照组相比,HBV C2在HCC患者中更为普遍。 HCC患者中HBV B2的比例从<30岁组连续下降到50-59岁组(P = 0.024)。与肝炎患者相比,HBV B2和基因型混合物的HCC患者与年龄相关的HBeAg血清学改变与血清病毒载量不一致。通过多因素回归分析,年龄≥40岁和血清病毒载量(≥10000拷贝/ ml)与肝癌发生独立相关,而年龄≤50岁和HBV B2与手术切除后肝癌复发独立相关。 。总之,具有两种或三种基因型的HBV合并感染与更高的病毒载量和更严重的病程相关。 HBV B2感染与HCC复发有关。 HCC患者中HBV C2优势与华东地区的高流行有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号